Organization · Type 2 NPI
Charles H. Boniske M.d, Inc.
Rheumatology Physician · Visalia, CA
NPI number
1942739461
Active
Practice location
400 W Mineral King Ave
Visalia, CA 93291-6237
Mailing address
5319 W Hillsdale Ave
Visalia, CA 93291-5118
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Rheumatology Physician Primary | 207RR0500X | None listed |
Rheumatology Physician: An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and "collagen" diseases.
478 other providers at this address
- Amari Medical CorpFamily Medicine Physician Visalia, CA NPI 1073138608
- Ash Ghaly MD IncGeneral Practice Physician Visalia, CA NPI 1073753356
- Carlos Rangel MD Medical CorporationObstetrics & Gynecology Physician Visalia, CA NPI 1568145928
- Central California Pediatric Specialty Medical Group IncSpecialist Visalia, CA NPI 1871871624
- Cep America - CaliforniaEmergency Medicine Physician Visalia, CA NPI 1558511147
- Diego Inc.Certified Registered Nurse Anesthetist Visalia, CA NPI 1174280309
- Exeter Health Medical Group IncFamily Medicine Physician Visalia, CA NPI 1730447715
- Greg Warner MD IncorporatedPulmonary Disease Physician Visalia, CA NPI 1710641550
- Horizon Critical Care Medical Group, Inc.Critical Care Medicine (Internal Medicine) Physician Visalia, CA NPI 1770904690
- Intensivist Critical Care Medical Group IncCritical Care Medicine (Internal Medicine) Physician Visalia, CA NPI 1861704116
- Kaweah Delta Health Care DistrictGeneral Acute Care Hospital Visalia, CA NPI 1588663769
- Kaweah Delta Health Care DistrictRadiology Clinic/Center Visalia, CA NPI 1699656330
Other rheumatology physician providers in Visalia
About NPI 1942739461
Charles H. Boniske M.d, Inc.'s National Provider Identifier is 1942739461, issued on Jun 8, 2017. The primary taxonomy on file is Rheumatology Physician (207RR0500X), and the practice location is in Visalia, CA. The record was last updated on Jan 11, 2023.